diabetes

  1. madman

    The Diabetes Pandemic: What You Need to Know

    https://vimeo.com/894561902?share=copy 1:50-18:23
  2. madman

    Personalized Nutrition Therapy Promotes Diabetes Remission

    https://www.medscape.com/viewarticle/personalized-nutrition-therapy-promotes-diabetes-remission-2023a1000uj2
  3. Nelson Vergel

    People with better humor control blood sugar better

    https://www.mdedge.com/endocrinology/article/266601/diabetes/does-laughter-offer-better-blood-glucose-control?ecd=WNL_EVE_231118_mdedge
  4. madman

    Making Sense of Semaglutide in Type 1 Diabetes

    https://www.hcplive.com/view/diabetes-dialogue-making-sense-of-semaglutide-in-type-1-diabetes In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, including the implications of the findings and...
  5. madman

    T therapy may lower HbA1c for men with T2DM and hypogonadism

    https://www.healio.com/news/endocrinology/20231004/testosterone-therapy-may-lower-hba1c-for-men-with-type-2-diabetes-hypogonadism Key takeaways: Men with type 2 diabetes and hypogonadism receiving testosterone therapy had reductions in HbA1c at 3 months, 1 year, and 2 years. More data are...
  6. madman

    Are PDE-5 Inhibitors Cardioprotective?

  7. madman

    Semaglutide Could Eliminate Need for Insulin in Type 1 Diabetes

    https://www.hcplive.com/view/semaglutide-could-eliminate-need-for-insulin-in-type-1-diabetes A case series of 10 patients with newly diagnosed type 1 diabetes provides insight into the beneficial effects of off-label semaglutide use on insulin use, HbA1c, and fasting C-peptide levels among...
  8. madman

    PCOS: A challenging condition with both reproductive and metabolic components

    Dr. Kathleen Hoeger discusses PCOS, a challenging condition with both reproductive and metabolic components. Diagnosis involves evaluating menstrual cycling, androgenic symptoms, and the appearance of the ovaries on ultrasound. Treatment varies depending on the individual’s needs and may include...
  9. madman

    Diabetes and erectile dysfunction

    Diabetic patients frequently have erection problems. However, diabetes can decrease erections by many ways. It is important to know what are the mechanism because there are different solutions. If you are diabetic and Viagra does not work, it is important to have a consultation to find...
  10. madman

    PDE5Is' growing role in men with diabetes and heart disease

    https://wchh.onlinelibrary.wiley.com/doi/full/10.1002/tre.926 PDE5 inhibitors can lower mortality and morbidity in men with type 2 diabetes and erectile dysfunction, but they are underused in this group. ED: An autonomous risk factor PDE5 inhibitors (PDE5Is) can reduce mortality and...
  11. madman

    Additional TRAVERSE data on testosterone therapy coming soon

    “Because this was the largest trial ever of testosterone replacement therapy, although the primary point of the trial was cardiovascular safety, we embedded within the trial several efficacy and other sub-studies,” says A. Michael Lincoff, MD...
  12. phalloguy100

    Increased testosterone effects on blood sugar?

    Random question… would getting higher/optimal testosterone levels have an effect on blood glucose and/or insulin sensitivity? This maybe a total coincidence, but I stopped clomid and restarted androgel. About a week into it, I’ve been getting some hypoglycemic episodes (I wear a dexcom cgm and...
  13. phalloguy100

    Twice daily cialis?

    I was recently prescribed cialis 2.5mg daily for E.D. I also have a recent diabetes diagnosis and I’m working on weight loss to try to reverse it. Although I feel like an old grandpa taking ED meds, truthfully I need it (especially after my endo’s failed experiment with clomid and stopping TRT…...
  14. madman

    Newer Glucose-Lowering Therapies in Older Adults with T2DM

    Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes (2023) Anika Bilal, MBBS, Richard E. Pratley, MD INTRODUCTION As life expectancy increases around the world, clinicians are increasingly faced with the formidable task of managing older adults with multiple diseases...
  15. madman

    Metabolic effects of L-citrulline in type 2 diabetes

    Metabolic effects of L-citrulline in type 2 diabetes (2023) Fatemeh Bagheripour, Sajad Jeddi, Khosrow Kashfi, Asghar Ghasemi Abstract The prevalence of type 2 diabetes (T2D) is increasing worldwide. Decreased nitric oxide (NO) bioavailability is involved in the pathophysiology of T2D and its...
  16. madman

    Hypogonadotropic Hypogonadism in Diabesity

    Hypogonadotropic Hypogonadism in Diabesity: Pathogenic Factors and Therapeutic Implications (2022) Paresh Dandona, * Sandeep Dhindsa, and Husam Ghanim Hypogonadotropic hypogonadism (HH) was found to occur in 33% of male patients with type 2 diabetes.1 These patients had low total and free...
  17. madman

    The metabolic role of prolactin

    The metabolic role of prolactin: systematic review, meta-analysis and preclinical considerations (2022) Giovanni Corona, Giulia Rastrelli, Paolo Comeglio, Federica Guaraldi, Diego Mazzatena, Alessandra Sforza , Linda Vignozzib and Mario Maggi ABSTRACT Introduction: Hyperprolactinemia has...
  18. madman

    Testosterone for Diabetes Mellitus (T4DM) Study with Dr. Abe Morgentaler

    The T4DM study is the world's largest, randomized, controlled trial of testosterone therapy. The study found that testosterone treatment greatly reduced the number of men who progressed to real diabetes. There was also a percentage of men who started the study with diabetes and by the end of the...
  19. madman

    Tirzepatide - First in a new class of diabetes medication (Part 2)

    Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.
  20. madman

    Tirzepatide - First in a new class of diabetes medication (Part 1)

    Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.
  21. elsoar

    About my concern with my son eating habits

    I just wanted to talk with forum about my concern with my son eating habits. I'm concerned that my son current safe foods are going to cause him to have diabetes and was curious if anyone feels like this or has there child health resulted in diabetes. I have already taken away fruit snacks and...
  22. madman

    40% of men with type 2 diabetes have symptomatic testosterone deficiency

    On-Demand webinar: 40% of men with type 2 diabetes have symptomatic testosterone deficiency – why are we still not finding and treating these men? https://abcd.care/resource/demand-webinar-40-men-type-2-diabetes-have-symptomatic-testosterone-deficiency-%E2%80%93-why-are-we In the fourth of our...
  23. madman

    Diabetes and Microvascular Complications

    Diabetes-Related Microvascular Complications – A Practical Approach (2022) Basem M. Mishriky, MD, Doyle M. Cummings, Pharm, FCP, FCCP, James R. Powell, MD DIABETIC SYMMETRIC POLYNEUROPATHY What is Diabetic Symmetric Polyneuropathy? Diabetic neuropathy is classified into diffuse neuropathy...
  24. madman

    Testosterone and Diabetes (Risk/Prevention)

    Testosterone, Diabetes Risk, and Diabetes Prevention in Men (2022) Bu B. Yeap, MBBS, Ph.D. *, Gary A. Wittert, MBBCh, MD INTRODUCTION Obesity is increasingly prevalent in developed and developing countries and contributes to increasing rates of type 2 diabetes (T2D) globally.1,2 In addition...
  25. madman

    Diabetes and Sexuality

    This ISSM Webinar will be about Diabetes and Sexuality. Medical comorbidities often have a significant impact on sexuality either directly or indirectly secondary to medical interventions. In addition to the physical aspects, chronic illness can also lead to significant psychological burdens...
  26. madman

    Stem cell therapy and diabetic ED

    Abstract Erectile dysfunction (ED) has been identified as one of the most frequent chronic complications of diabetes mellitus (DM). The prevalence of ED is estimated to be about 67.4% in all DM cases worldwide. The pathophysiological process leading to ED involves endothelial, neurological...
  27. madman

    Erectile dysfunction and diabetes

    Abstract Diabetes mellitus (DM), a chronic metabolic disease characterized by elevated levels of blood glucose, is among the most common chronic diseases. The incidence and prevalence of DM have been increasing over the years. The complications of DM represent a serious health problem. The...
  28. M

    THRYOID REPLACEMENT MEDS & GLUCOSE LEVELS

    Has anyone noticed an increased in glucose readings, specifically fasting glucose, after taking any thyroid replacement meds for some time (i.e. Armour, Synthroid, etc.)? According to this article, "The levothyroxine elevated the patient’s blood sugar to the point where hypoglycemia resolved...
  29. J

    Exogenous Testosterone Decreases Diabetes Risk

    A new placebo controlled study of the use of testosterone undecanoate to prevent type 2 diabetes in older obese men found it reduced the risk by 40%. The study was presented at the recent meeting of the American Diabetes Association, the abstract is online. There is also an article about the...
  30. Systemlord

    Mineral deficiencies and diabetes assistance needed.

    I had restarted TRT recently and within 24 hours experience a period of little to no urination, followed by a return of urination 5 days later and even better than pre-TRT. Things are going great, then followed by a vitamin C deficiency which I averted by simply doubling the portion, but then...
  31. J

    TRT and the Management of T2D

    Two studies recently in the news show the effectiveness of testosterone replacement therapy in the management of tupe 2 diabetes. The first was presented at the Endocrine Society Annual Meeting. An observational registry study of 462 men with obesity and hypogonadism. Among the cohort, 273 men...
Back
Top